Virtus ETF Advisers LLC Dynavax Technologies Corp Transaction History

Virtus ETF Advisers LLC

$234 Million
Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 26,917 shares of DVAX stock, worth $371,185. This represents 0.15% of its overall portfolio holdings.

Number of Shares

26,917

Previous 27,423 1.85%

Holding current value

$371,185

Previous $305,000 12.46%

% of portfolio

0.15%

Previous 0.15%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$10.28 - $13.66 $5,201 - $6,911	-506 Reduced 1.85%	26,917 $343,000
Q2 2024 Aug 14, 2024	BUY	$10.73 - $12.58 $225,769 - $264,695	21,041 Added 329.69%	27,423 $307,000
Q1 2024 May 15, 2024	SELL	$11.7 - $14.98 $5,159 - $6,606	-441 Reduced 6.46%	6,382 $79,000
Q4 2023 Feb 15, 2024	SELL	$13.09 - $14.98 $13,194 - $15,099	-1,008 Reduced 12.87%	6,823 $95,000
Q3 2023 Nov 07, 2023	SELL	$12.64 - $14.99 $9,922 - $11,767	-785 Reduced 9.11%	7,831 $115,000
Q2 2023 Aug 14, 2023	SELL	$9.85 - $13.17 $1,379 - $1,843	-140 Reduced 1.6%	8,616 $111,000
Q1 2023 May 15, 2023	SELL	$9.44 - $11.88 $31,822 - $40,047	-3,371 Reduced 27.8%	8,756 $85,000
Q4 2022 Feb 14, 2023	BUY	$10.27 - $13.29 $22,152 - $28,666	2,157 Added 21.63%	12,127 $129,000
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $655 - $1,151	66 Added 0.67%	9,970 $104,000
Q2 2022 Aug 12, 2022	SELL	$7.45 - $12.83 $12,575 - $21,657	-1,688 Reduced 14.56%	9,904 $125,000
Q1 2022 May 16, 2022	SELL	$9.75 - $14.44 $6,678 - $9,891	-685 Reduced 5.58%	11,592 $126,000
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $148,755 - $236,517	-11,295 Reduced 47.92%	12,277 $173,000
Q3 2021 Nov 15, 2021	SELL	$9.16 - $19.83 $11,239 - $24,331	-1,227 Reduced 4.95%	23,572 $453,000
Q2 2021 Aug 10, 2021	SELL	$7.25 - $10.99 $241,359 - $365,868	-33,291 Reduced 57.31%	24,799 $244,000
Q1 2021 May 17, 2021	BUY	$4.57 - $11.18 $4,697 - $11,493	1,028 Added 1.8%	58,090 $571,000
Q4 2020 Feb 12, 2021	BUY	$3.73 - $5.6 $11,480 - $17,236	3,078 Added 5.7%	57,062 $254,000
Q3 2020 Nov 13, 2020	SELL	$4.32 - $11.7 $31,739 - $85,959	-7,347 Reduced 11.98%	53,984 $233,000
Q2 2020 Aug 05, 2020	BUY	$2.94 - $9.1 $180,313 - $558,112	61,331 New	61,331 $544,000
Q1 2019 May 14, 2019	SELL	$7.08 - $12.09 $409,493 - $699,261	-57,838 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$8.14 - $13.28 $70,060 - $114,300	8,607 Added 17.48%	57,838 $529,000
Q3 2018 Nov 14, 2018	BUY	$11.85 - $16.0 $39,306 - $53,072	3,317 Added 7.22%	49,231 $610,000
Q2 2018 Aug 10, 2018	SELL	$15.15 - $20.75 $30,057 - $41,168	-1,984 Reduced 4.14%	45,914 $700,000
Q1 2018 May 14, 2018	SELL	$14.65 - $19.9 $41,430 - $56,277	-2,828 Reduced 5.58%	47,898 $951,000
Q4 2017 Feb 14, 2018	BUY	$17.3 - $24.08 $335,706 - $467,272	19,405 Added 61.96%	50,726 $949,000
Q3 2017 Nov 14, 2017	SELL	$15.2 - $21.5 $104,211 - $147,404	-6,856 Reduced 17.96%	31,321 $673,000
Q2 2017 Aug 14, 2017	BUY	N/A	38,177	38,177 $368,000

Others Institutions Holding DVAX

# of Institutions

288

Shares Held

131M

Call Options Held

507K

Put Options Held

374K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.74B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Dynavax Technologies Corp Transaction History